Arcus Biosciences RCUS Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$369M-4.5% | -$353M-3.5% | -$341M-14.4% | -$298M+23.8% | -$391M-38.2% | ||
| $9M-10.0% | $10M0.0% | $10M0.0% | $10M0.0% | $10M0.0% | ||
| $63M+5.0% | $60M-3.2% | $62M-7.5% | $67M-6.9% | $72M-5.3% | ||
| -$488M-1.2% | -$482M-4.3% | -$462M— | —— | —— | ||
| —— | —— | —— | —— | $3M-50.0% | ||
| —— | —— | —— | —— | —— | ||
| $349M-28.5% | $488M+142% | $202M-16.5% | $242M+26.0% | $192M-31.2% | ||
| —— | —— | —— | —— | —— | ||
| -$489M-1.0% | -$484M-4.3% | -$464M— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Arcus Biosciences generate?
- Arcus Biosciences (RCUS) generated -$488.0M in operating cash flow over the trailing twelve months.
- What is Arcus Biosciences's free cash flow?
- After $3.0M of capital expenditures, Arcus Biosciences's free cash flow was -$489.0M over the trailing twelve months, down 46.4% year over year.
- Where does Arcus Biosciences's cash flow data come from?
- Every line is extracted from Arcus Biosciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
